Klin Monbl Augenheilkd 2002; 219(5): 333-339
DOI: 10.1055/s-2002-32637
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Strategien zur Behandlung der Limbusstammzellinsuffizienz

Surgical approaches for limbal stem cell deficiencyMartin  Grüterich1 , Scheffer  C. G.  Tseng2
  • 1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine
  • 2Ocular Surface Center and Ocular Surface Research & Education Foundation, Miami, Florida, USA
Experimentelle Ergebnisse dieser Arbeit wurden über ein Forschungsstipendium an M. G. der Deutschen Forschungsgemeinschaft (DFG), Bonn (GR 1814/1-1 und 1-2), unterstützt
Further Information

Publication History

14. 3. 2002

3. 5. 2002

Publication Date:
02 July 2002 (online)

Zusammenfassung

Hintergrund: Die im basalen Limbusepithel lokalisierten Stammzellen des sich ständig erneuernden Epithels der Hornhaut können durch unterschiedliche Erkrankungen beeinträchtigt werden und so das klinische Bild der Limbusstammzellinsuffizienz (LI) hervorrufen. Das Hauptmerkmal der LI stellt die Konjunktivalisierung der Hornhautoberfläche dar. Verschiedene Strategien zum therapeutischen Vorgehen sollten berücksichtigt werden. Methoden und Ergebnisse: Erstes Ziel der Behandlung sollte die Wiederherstellung der Schutzmechanismen der Augenoberfläche sein, die einen stabilen Tränenfilm gewährleisten. Erst dann sollten weitere chirurgische Maßnahmen erfolgen. Zur Verfügung stehen die superfizielle Keratektomie mit oder ohne Amniontransplantation, die autologe Konjunktiva-Limbus-Transplantation und die homologe Kerato-Limbus-Transplantation. Destruktionen des Limbusstromas können mit Hilfe der Amniontransplantation therapeutisch angegangen werden. Tissue-engineering von Limbusepithel auf humaner Amnionmembran als biologischem Substrat und anschließender Transplantation stellt ein neues Verfahren zur Behandlung der LI dar. Schlussfolgerung: Die korrekte Diagnose sowie die Wiederherstellung der okulären Schutzmechanismen stellen die Grundvoraussetzung für die weitere chirurgische Rekonstruktion der Augenoberfläche dar. Trotz zum Teil sehr guter therapeutischer Ergebnisse sind weitere Untersuchungen zur Auswahl der Patienten für die zu wählende operative Technik sowie zur optimalen Immunsuppression erforderlich.

Abstract

Background: Stem cells are the ultimate source of the rapidly self-renewing corneal epithelium and are located in the basal layer of the limbal epithelium. A variety of diseases can compromise the stem cell pool, causing an entity called limbal stem cell deficiency. Several therapeutic strategies should be taken into account. Methods and results: Ocular surface defence should be restored prior to any kind of stem cell transplantation to assure a sufficient and stable tearfilm. Surgical strategies comprise superficial keratectomy with or without amniotic membrane transplantation, conjunctival-limbal autograft and keratolimbal allograft transplantation. A damaged limbal and corneal stroma can be reconstructed by amniotic membrane as a biological substrate. First encouraging results have been reported using tissue bio-engineered limbal epithelium on amniotic membrane for corneal surface reconstruction. Conclusion: The correct diagnosis and a restored ocular surface defence are a prerequisite for subsequent transplantation of limbal stem cells. Optimal patient selection for the respective surgical approach and systemic immunosuppression protocols to improve allograft survival need to be further investigated.

Literatur

  • 1 Basti S, Mathur U. Unusual intermediate-term outcome in three cases of limbal autograft transplantation.  Ophthalmology. 1999;  106 958-963
  • 2 Chen J JY, Tseng S CG. Corneal epithelial wound healing in partial limbal deficiency.  Invest Ophthalmol Vis Sc. 1990;  31 1301-1314
  • 3 Chen J JY, Tseng S CG. Abnormal corneal epithelial wound healing in partial thickness removal of limbal epithelium.  Invest Ophthalmol Vis Sci. 1991;  32 2219-2233
  • 4 Dua H S. The conjunctiva in corneal epithelial wound healing.  Br J Ophthalmol. 1998;  82 1411
  • 5 Dua H S, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency.  Br J Ophthalmol. 1999;  83 414-419
  • 6 Dua H S, Azuara-Blanco A. Amniotic membrane transplantation.  Br J Ophthalmol. 1999;  83 748-752
  • 7 Dua H S, Azuara-Blanco A. Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency.  Br J Ophthalmol. 2000;  84 273-278
  • 8 Dua H S, Gomes J AP, Singh A. Corneal epithelial wound healing.  Br J Ophthalmol. 1994;  78 401-408
  • 9 Gris O, Guell J L, Del C ampo. Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium.  Ophthalmology. 2000;  107 270-273
  • 10 Grueterich M, Espana E, Tseng S C. Connexin 43 expression and proliferation of human limbal epithelium on intact and denuded amniotic membrane.  Invest Ophthalmol Vis Sci. 2002;  43 63-71
  • 11 Grueterich M, Espana E M, Touhami A, Ti S-E, Tseng S CG. Phenotypic study of a case with successful transplantation of ex vivo expanded human limbal epithelium for unilateral total limbal stem cell deficiency.  Ophthalmolog. 2002, in press; 
  • 12 Grueterich M, Tseng S CG. Human limbal progenitor cells expanded on intact amniotic membrane.  Arch Ophthalmol. 2002, in press; 
  • 13 Holland E J. Epithelial transplantation for the management of severe ocular surface disease.  Trans Am Ophthalmol Soc. 1996;  94 677-743
  • 14 Holland E J, Schwartz G S. The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system.  Cornea. 1996;  15 549-556
  • 15 Huang A JW, Tseng S CG, Kenyon K R. Alteration of epithelial paracellular permeability during corneal epithelial wound healing.  Invest Ophthalmol Vis Sci. 1990;  31 429-435
  • 16 Jenkins C, Tuft S, Liu C, Buckley R. Limbal transplantation in the management of chronic contact-lens-associated epitheliopathy.  Eye. 1993;  7 629-633
  • 17 Kenyon K R, Rapoza P A. Limbal allograft transplantation for ocular surface disorders.  Ophthalmology. 1995;  102 (Suppl) 101-102
  • 18 Kenyon K R, Tseng S CG. Limbal autograft transplantation for ocular surface disorders.  Ophthalmology. 1989;  96 709-723
  • 19 Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders.  Ophthalmology. 2001;  108 1569-1574
  • 20 Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial transplantation for ocular surface reconstruction in acute phase of Stevens-Johnson syndrome.  Arch Ophthalmol. 2001;  119 298-300
  • 21 Kruse F E, Voelcker H E, Rohrschneider K. Amniotic membrane transplantation (AMT) for ocular surface reconstruction.  Ophthalmologe. 1998;  95 114-119
  • 22 Kruse F E, Reinhard T. Die Limbustransplantation zur Rekonstruktion der Augenoberfläche.  Ophthalmologe. 2001;  98 818-831
  • 23 Kruse F E, Meller D. Die Amnionmembrantransplantation zur Rekonstruktion der Augenoberfläche.  Ophthalmologe. 2001;  98 801-810
  • 24 Meller D, Pires R TF, Tseng S CG. Ex vivo preservation and expansion of human limbal epithelial progenitor cells by amniotic membrane.  Br J Ophthalmol. 2002;  86 463-471
  • 25 Morgan S, Murray A. Limbal autotransplantation in the acute and chronic phases of severe chemical injuries.  Eye. 1996;  10 349-354
  • 26 Nishida K, Kinoshita S, Ohashi Y, Kuwayama Y, Yamamoto S. Ocular surface abnormalities in aniridia.  Am J Ophthalmol. 1995;  120 368-375
  • 27 Puangsricharern V, Tseng S CG. Cytologic evidence of corneal diseases with limbal stem cell deficiency.  Ophthalmology. 1995;  102 1476-1485
  • 28 Reinhard T, Reis A, Bohringer D. et al . Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial.  Graefes Arch Clin Exp Ophthalmol. 2001;  239 367-372
  • 29 Schwab I R, Reyes M, Isseroff R R. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease.  Cornea. 2000;  19 421-426
  • 30 Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon.  Br J Ophthalmol. 1998;  82 235-240
  • 31 Shimazaki J, Yang H-Y, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns.  Ophthalmology. 1997;  104 2068-2076
  • 32 Sippel K C, Ma J JK, Foster C S. Amniotic membrane surgery.  Curr Opin Ophthalmol. 2001;  12 269-281
  • 33 Solomon A, Ellies P, Anderson D F. et al .Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 2001 109, in press
  • 34 Solomon A, Touhami A, Sandoval H, Tseng S CG. Neurotrophic keratopathy: basic concepts and therapeutic strategies.  Comp Ophthalmol Update. 2000;  3 165-174
  • 35 Tan D TH, Ficker L A, Buckley R J. Limbal transplantation.  Ophthalmology. 1996;  103 29-36
  • 36 Theng J TS, Tan D TH. Combined penetrating keratoplasty and limbal allograft transplantation for severe corneal burns.  Ophthalmic Surg Lasers. 1997;  28 765-768
  • 37 Tsai R JF, Li L-M, Chen J-K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells.  N Eng J Med. 2000;  343 86-93
  • 38 Tsai R JF, Tseng S CG. Human allograft limbal transplantation for corneal surface reconstruction.  Cornea. 1994;  13 389-400
  • 39 Tseng S CG. Regulation and clinical implications of corneal epithelial stem cells.  Mol Biol Rep. 1996;  23 47-58
  • 40 Tseng S CG, Chen J JY, Huang A JW, Kruse F E, Maskin S L, Tsai R JF. Classification of conjunctival surgeries for corneal disease based on stem cell concept.  Ophthalmol Clin North Am. 1990;  3 595-610
  • 41 Tseng S CG, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency.  Arch Ophthalmol. 1998;  116 431-441
  • 42 Tseng S CG, Tsubota K. Important concepts for treating ocular surface and tear disorders.  Am J Ophthalmol. 1997;  124 825-835
  • 43 Tseng S CG, Tsubota K. Amniotic Membrane Transplantation for Ocular Surface Reconstruction. In: Holland EJ, Mannis MJ (eds) Ocular Surface Disease. New York, Berlin, Heidelberg; Springer 2002: 226-231
  • 44 Tsubota K, Satake Y, Kaido M. et al . Treatment of severe ocular surface disorders with corneal epithelial stem-cell transplantation.  N Eng J Med. 1999;  340 1697-1703
  • 45 Tsubota K, Satake Y, Ohyama M. et al . Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome.  Am J Ophthalmol. 1996;  122 38-52
  • 46 Tsubota K, Shimazaki J. Surgical treatment of children blinded by Stevens-Johnson syndrome.  Am J Ophthalmol. 1999;  128 573-581
  • 47 Tsubota K, Toda I, Saito H, Shinozaki N, Shimazaki J. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders.  Ophthalmology. 1995;  102 1486-1496

Scheffer C. G. Tseng,M. D., Ph. D. 

Ocular Surface Center and Ocular Surface Research & Education Foundation · 8780 SW

92nd Street

Miami, FL 33176 · USA

Email: stseng@ocularsurface.com